Clinical Trials Directory

Trials / Completed

CompletedNCT06556849

Effectiveness of DIMS Spectacle as a Function of the Age

Effectiveness of Defocus Incorporated Multiple Segments in Slowing Myopia Progression as a Function of the Age in Pediatric Patients. Three Years Follow up.

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Luca Buzzonetti · Academic / Other
Sex
All
Age
6 Years – 16 Years
Healthy volunteers
Not accepted

Summary

Purpose: To evaluate the effectiveness of Defocus Incorporated Multiple Segments (DIMS) in slowing myopia progression as a function of age in pediatric patients. Methods: This was a non-randomized experimenter-masked retrospective controlled observational study of European individuals aged 6 -16 years with progressive myopia but no ocular pathology. The charts of the participants allocated to receive DIMS spectacles (Hoya® MiyoSmart®) or single vision spectacle lenses (control group) were retrospectively reviewed. The key outcome variables, cycloplegic spherical equivalent (SE) and axial length (AL), were measured at baseline and at 36 month follow up. The results were stratified by age into four groups: patients that wore DIMS spectacles oldest or youngest than 10 years (respectively, group A, 20 patients mean age 13.6±2.2 and group C, 20 patients mean age 9.0±1.2) and age matched control groups (group B, 18 patients mean age 13.2±2.5 and group D, mean age 8.5±0.9).

Detailed description

Participants were allocated to the study groups, receiving DIMS spectacles, or to the control groups, wearing single vision spectacle lenses.

Conditions

Interventions

TypeNameDescription
DEVICEDefocus Incorporated Multiple Segments (DIMS)To evaluate the effectiveness of Defocus Incorporated Multiple Segments (DIMS) in slowing myopia progression as a function of age in pediatric patients.

Timeline

Start date
2020-12-01
Primary completion
2020-12-01
Completion
2024-06-30
First posted
2024-08-16
Last updated
2024-08-20

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06556849. Inclusion in this directory is not an endorsement.